These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 29153068

  • 1. [Atypical profile problem in serological diagnosis of EBV].
    Varıcı Balcı FK, Özbek ÖA, Sayıner AA.
    Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068
    [Abstract] [Full Text] [Related]

  • 2. Investigation of atypical serological profiles for Epstein-Barr virus (EBV).
    Portet Sulla V, Kadi A, Mouna L, Fenaux H, Cechura H, Rafek R, Di Ciccone JL, Warnakulasuriya F, Vauloup-Fellous C.
    J Virol Methods; 2024 Sep; 329():115002. PubMed ID: 39067186
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW, Myrmel H.
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O, Ozkaratas MH, Sayiner AA.
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [Abstract] [Full Text] [Related]

  • 5. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S, Feghoul L, Salmona M, Herda A, Mercier-Delarue S, Simon F, Legoff J.
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [Abstract] [Full Text] [Related]

  • 6. The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections.
    Huang Y, Wei C, Zheng K, Zhao D.
    Virol J; 2013 Feb 13; 10():55. PubMed ID: 23406068
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I, Giménez E, Navarro D.
    Clin Vaccine Immunol; 2014 May 13; 21(5):684-8. PubMed ID: 24623623
    [Abstract] [Full Text] [Related]

  • 8. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern.
    De Paschale M, Agrappi C, Manco MT, Mirri P, Viganò EF, Clerici P.
    J Med Virol; 2009 Feb 13; 81(2):325-31. PubMed ID: 19107979
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S, Vallières E, Rabaamad L, Labrecque M, Chartrand C, Renaud C.
    J Clin Virol; 2016 Aug 13; 81():1-5. PubMed ID: 27258036
    [Abstract] [Full Text] [Related]

  • 11. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D, Nadkar M, Rajadhyaksha A, Pandit-Shende P, Surve P, Dawkar N, Khadilkar P, Patwardhan M, Kaveri S, Ghosh K, Pradhan V.
    J Med Virol; 2018 Mar 13; 90(3):559-563. PubMed ID: 28734074
    [Abstract] [Full Text] [Related]

  • 12. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I, Hinderer W, Rothe M, Lang D, Sonneborn HH, Wutzler P.
    J Med Virol; 2001 Apr 13; 63(4):271-6. PubMed ID: 11241457
    [Abstract] [Full Text] [Related]

  • 13. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J, Yan W, Xu S, Wang Q, Zhang W, Liu W, Ni A.
    PLoS One; 2018 Apr 13; 13(3):e0193171. PubMed ID: 29494658
    [Abstract] [Full Text] [Related]

  • 14. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A.
    J Med Virol; 2003 Aug 13; 70(4):617-23. PubMed ID: 12794726
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of three different assays for the assessment of Epstein Barr Virus immunological status.
    Altuglu I, Bozkurt H, Samlioglu P, Zeytinoglu A.
    New Microbiol; 2007 Oct 13; 30(4):393-8. PubMed ID: 18080674
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S, Ersoy A, Sevinir BB, Sınırtaş M, Göral G.
    Mikrobiyol Bul; 2012 Oct 13; 46(4):594-606. PubMed ID: 23188573
    [Abstract] [Full Text] [Related]

  • 17. Determination of serological profiles and avidity of specific antibodies in the sera of patients with potential Epstein-Barr virus (EBV) infection.
    Akpolat N, Gedik M, Nergiz S, Bilek H.
    Bratisl Lek Listy; 2013 Oct 13; 114(8):460-3. PubMed ID: 23944621
    [Abstract] [Full Text] [Related]

  • 18. Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.
    Lupo J, Germi R, Semenova T, Buisson M, Seigneurin JM, Morand P.
    Clin Vaccine Immunol; 2012 Jun 13; 19(6):929-34. PubMed ID: 22539474
    [Abstract] [Full Text] [Related]

  • 19. Evidence-based approach for interpretation of Epstein-Barr virus serological patterns.
    Klutts JS, Ford BA, Perez NR, Gronowski AM.
    J Clin Microbiol; 2009 Oct 13; 47(10):3204-10. PubMed ID: 19656988
    [Abstract] [Full Text] [Related]

  • 20. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T, Cetin E, Kaşifoğlu N, Kaşifoğlu T, Akgün Y.
    Mikrobiyol Bul; 2011 Oct 13; 45(4):677-83. PubMed ID: 22090298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.